Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.
Ann Clin Microbiol Antimicrob. 2021 Mar 16;20(1):17. doi: 10.1186/s12941-021-00420-3.
Abnormal laboratory findings are common in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this systematic review was to investigate the effect of the level of some laboratory factors (C-reactive protein (CRP), creatinine, leukocyte count, hemoglobin, and platelet count) on the severity and outcome of coronavirus disease 2019 (COVID-19).
We searched PubMed, Web of Science, Scopus, and Google Scholar. We collected the articles published before May 26, 2020. We gathered the laboratory factors in groups of patients with COVID-19, and studied the relation between level of these factors with severity and outcome of the disease.
Mean CRP level, creatinine, hemoglobin, and the leukocytes count in the critically ill patients were significantly higher than those of the other groups (non-critical patients); mean CRP = 54.81 mg/l, mean creatinine = 86.82 μmol/l, mean hemoglobin = 144.05 g/l, and mean leukocyte count = 7.41 × 10. The lymphocyte count was higher in patients with mild/moderate disease (mean: 1.32 × 10) and in the invasive ventilation group (mean value of 0.72 × 10), but it was considerably lower than those of the other two groups. The results showed that the platelet count was higher in critically ill patients (mean value of 205.96 × 10). However, the amount was lower in the invasive ventilation group compared with the other groups (mean level = 185.67 × 10).
With increasing disease severity, the leukocyte count and the level of CRP increase significantly and the lymphocyte count decreases. There seems to be a significant relation between platelet level, hemoglobin, and creatinine level with severity of the disease. However, more studies are required to confirm this.
感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的患者常出现异常实验室检查结果。本系统评价的目的是调查一些实验室因素(C 反应蛋白(CRP)、肌酐、白细胞计数、血红蛋白和血小板计数)的水平对 2019 年冠状病毒病(COVID-19)严重程度和结局的影响。
我们检索了 PubMed、Web of Science、Scopus 和 Google Scholar。我们收集了 2020 年 5 月 26 日前发表的文章。我们将 COVID-19 患者的实验室因素分为几组,并研究这些因素水平与疾病严重程度和结局之间的关系。
危重症患者的平均 CRP 水平、肌酐、血红蛋白和白细胞计数明显高于其他组(非危重症患者);平均 CRP=54.81mg/l,平均肌酐=86.82μmol/l,平均血红蛋白=144.05g/l,平均白细胞计数=7.41×10。轻度/中度疾病患者的淋巴细胞计数较高(平均:1.32×10)和有创通气组(平均 0.72×10),但明显低于其他两组。结果表明,危重症患者的血小板计数较高(平均 205.96×10)。然而,与其他两组相比,有创通气组的血小板计数较低(平均水平=185.67×10)。
随着疾病严重程度的增加,白细胞计数和 CRP 水平显著升高,淋巴细胞计数降低。血小板水平、血红蛋白和肌酐水平似乎与疾病严重程度有显著关系。然而,需要更多的研究来证实这一点。